Navigation Links
Is There Any Clinical Benefit to Staying on a Failing Regimen?

The accumulation of drug resistance after the failure of an anti-HIV drug combination is slower in patients who had previously experienced only moderate// CD4 cell losses, according to a study of patients failing treatment at a network of European hospitals.

However, the study also found that on average, patients who remained on a failing regimen lost 1.25 active drugs from the choice still available to them for every six months on failing treatment, highlighting the need for prompt treatment switches wherever possible.

Participants in the study also showed minimal declines in their CD4 cell counts.

The results are published in the March 30th edition of the journal AIDS.

The development of drug resistance after treatment failure has led to the strong recommendation in various national treatment guidelines that treatment should be switched as soon as possible after virological failure is detected, and that resistance testing should be used in order to select the successor regimen.

However, not all patients are able to assemble a drug combination that will contain three fully active drugs, and researchers connected with the EuroSIDA cohort study wanted to assess how quickly people on failing drug regimens might accumulate further drug resistance mutations if they did not switch treatment.

They carried out a retrospective study using stored plasma samples from participants in the EuroSIDA cohort. Selected for study were patients who had been on a virologically failing regimen for at least six months, and thereafter, had two resistance tests during the period when viral load was below 400 copies/mL and who had also remained on an unchanged regimen containing at least three antiretrovirals.

Prior to their current failing regimen, on average, patients had previously used five other drugs and virologically failed one or more drug classes. Regimens being used included NRTIs, NNRTIs, single
'"/>




Page: 1 2 3

Related medicine news :

1. Could There Be A Link Between Famine and Breast Cancer ?
2. Can There Be A Diabetes Type III?
3. Diabetic Amputation May Reduce If Free Screenings Are There
4. Hospital Says There Is Time but Baby Decides Otherwise
5. WHO’s asking :Is There Light At The End Of The Tunnel In Tajikistan
6. There is light at the end of the blind tunnel: prosthetic retinal cells offer hope!
7. Is There A Strong Link Between Fluoride In Tap Water And Bone Cancer?
8. Is There a Connection between Hearing loss and High-speed Dental Tools?
9. Clinical trials need to be more frank
10. Physicians Lack Clinical Guidelines For Treating Elderly With Multiple Illnesses
11. The Growing Rise In Clinical Research Could Lead To A Compromise In Quality Of Research And Ethics
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: There Any Clinical Benefit Staying Failing Regimen

(Date:7/2/2015)... ... July 02, 2015 , ... Get ready ... SIGVARIS PERFORMANCE SOCKS. Since the socks were first introduced, they have rapidly been ... popularity has inspired four new, fun shades including: blue, lime, pink and red. ...
(Date:7/2/2015)... ... July 02, 2015 , ... The ZAC Foundation, a national leader ... with important lessons on how to stay water safe with the help of a ... authored by The ZAC Foundation co-founders, follows Zeke’s water safety journey. Zeke, who ...
(Date:7/2/2015)... , ... July 02, 2015 ... ... therapy (NPWT) - pipeline review 2015” provides comprehensive information on the pipeline ... Complete report on negative pressure wound therapy (NPWT) with 22 market data ...
(Date:7/2/2015)... ... July 02, 2015 , ... Facial plastic ... and precision. There is an art and science that goes into successful facial ... reshaping the facial features and lives of more than 2,500 satisfied facelift and ...
(Date:7/2/2015)... , ... July 02, 2015 , ... ... and management consulting services to the federal government, has announced they are among ... (IDIQ), Business Management Office Support Services (BMOSS) contract not to exceed $250 million. ...
Breaking Medicine News(10 mins):Health News:SIGVARIS is Sporting Four Brand New Colors in the Popular PERFORMANCE SOCK Product Line 2Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 2Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 3Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 2Health News:Dr. Kevin Sadati Featured in July Issue of Popular National Magazines 3Health News:Octo Consulting Group Awarded IDIQ Contract for SEC Business Management Support 2
... New Messages On Nutrition, Fitness and Lifestyle ... SusanPowterOnline.com ... Eat, Breathe, Move, Think, NEW YORK, ... took a self-imposed exile after,creating the top-selling fitness product line "Stop The Insanity." That,exile ...
... Bravo Health announced,today that membership in its Medicare ... the past year, with enrollment now exceeding 100,000,members. ... included an,acquisition, market expansions and a name change., ... Senior Partners, a,Medicare health plan product serving approximately ...
... all about bringing,people together. But when a lot of ... more bacteria. Holiday guests mean there,s more traffic in ... areas like the bathroom.,Celebrity dentist Dr. Bill Dorfman says ... your toothbrush behind closed doors., , Listen to ...
... Stonecrest Medical Center will serve an estimated 15,000 ... Permanente opened its,15th medical center this week, to ... areas. An official ribbon cutting and,dedication ceremony for ... attended by Georgia State Senator Ron Ramsey, Georgia ...
... 4 The National,Organization of Life & Health ... state guaranty associations that are playing,a central role ... Executive Life,Insurance Company of New York (ELNY) matter., ... following statement,regarding the ELNY situation: "NOLHGA and all ...
... lessen symptoms , , TUESDAY, Dec. 4 (HealthDay News) -- ... placebo in combating sinus infections, a new British study ... have been previously believed, particularly for the majority of ... Williamson, a senior lecturer in primary medical care at ...
Cached Medicine News:Health News:Fitness Sensation Susan Powter Returns to Her Legions of Fans and Followers with Focus on Whole Body Wellness Program 2Health News:Kaiser Permanente Opens 15th Medical Facility in Georgia 2Health News:Statement on Executive Life of New York Matter 2Health News:Sinusitis Treatments Found Ineffective 2Health News:Sinusitis Treatments Found Ineffective 3
(Date:7/2/2015)... 2, 2015 Pharma Major Lupin Limited ... "Biocom" in Russia subject to certain ... pharmaceutical market which recorded RUB 765 billion in sales, placing ... the world in 2014 (IMS Health). For over a decade, ... continue with this trend, projecting Russia ...
(Date:7/2/2015)... 2015 Research ... addition of the "2015 New Frontiers ... Emerging Technologies, Competitive Landscape" report to ... in Clinical Chemistry and Immunodiagnostics: Global Challenges, ... seven-country strategic analysis of major business opportunities ...
(Date:7/2/2015)... , July 2, 2015  The Commission for ... with ASHP, an organization that represents pharmacists in ... provider of continuing education for recertification of Certified ... of geriatric programs for this purpose.  ASHP will ... authorized providers for the CCGP Professional Development Program. ...
Breaking Medicine Technology:Lupin Acquires Biocom in Russia 2Lupin Acquires Biocom in Russia 3New Frontiers in 2015 Global Clinical Chemistry and Immunodiagnostics Market: Challenges, Emerging Technologies, Competitive Landscape 2Commission for Certification in Geriatric Pharmacy Adds ASHP as Professional Development Program Provider 2
... a,biopharmaceutical company focused on the development of novel ... from its,Phase I safety and tolerability study of ... MRX-4 was nasally administered as a single ... first administration was given without a nasal,allergen challenge ...
... Applied,Biology, Inc. (FAB) announced today that it has ... IIB grant from the National,Science Foundation. The $500,000 ... cell-free protein synthesis technology towards commercialization., During ... Phase II,NSF projects, FAB successfully demonstrated that certain ...
Cached Medicine Technology:Morria Biopharmaceuticals Plc Announces Preliminary Safety and Tolerability Results From Its Phase I Clinical Study of MRX-4 in Allergic Rhinitis Patients 2Fundamental Applied Biology, Inc. Is Awarded SBIR Phase IIB Grant for the Commercialization of Protein Therapeutics Using Cell Free Technology 2
... Achieve high-speed productivity in the lab ... system, dedicated for pre- and post-analytical sorting ... HSS selectively decaps and then sorts primary ... to save time, labor, and eliminate ...
... Catering to the special needs ... Infant ThermoWrap™ protects the littlest ... their most vulnerable by providing ... continuous management of an infants ...
Cocoon Disposable Patient Warming Blankets are specially designed to prevent hypothermia and maintain normothermia in your patients. The soft warm coloured material is strong and resists tearing and ...
A smaller version of the Model 525 lower body blanket, this blanket is ideal for warming the large child or small adult during upper body surgery....
Medicine Products: